Chronic Disease Management Platform Rimidi Rebrands On the Heels of $6.5M Funding Round


Digital health startup Rimidi, formerly known as Rimidi Diabetes, has made its expanded mission official on the heels of a $6.575 million funding round. The capital came from new investors, pharmaceutical giant Eli Lilly and Company and Turner Investments, as well as existing investors Cox Enterprises, Village Capital, The Jump Fund and JAMB Global.

Prior to this, the startup had raised about $1.4 million. Rimidi was founded in 2012 by Dr. Lucienne Ide, a physician who also worked as a physicist at the NSA and at a venture capital firm; it is currently a portfolio company of Georgia Tech’s Advanced Technology Development Center (ATDC).

Dr. Ide founded Rimidi as a comprehensive health management platform to connect diabetes patients with their providers and help them develop personalized treatment plans. Its flagship product, a platform called Diabetes+Me, integrates with the patient’s electronic medical records and streamlines the healthcare workflow.

Recently, though, the startup has expanded beyond diabetes and into other chronic conditions, most notably heart disease. Last year, they launched a heart failure platform which enables improved monitoring of heart failure patients, decreasing the likelihood of readmissions.

Dr. Ide says this capital will enable the company to expand into developing additional condition-specific tools, as well as focus on sales and marketing for existing products. The current team of 10 will expand to cover new clients and partnerships.

At the beginning of this year, the company also brought in a new CEO, business leader Josh Claman, as an addition to the leadership team. Dr. Ide remains chairman of the board of directors. 

With Claman’s entrance into the company, Rimidi will open an additional office in his hometown of Austin, TX. Dr. Ide says they look forward to getting involved in the Austin tech scene and drawing on the talent that comes out of the University of Texas and its medical school.

The majority of the team will remain in Atlanta, where the startup continues to collaborate with local organizations. They’re currently working with the Atlanta Regional Collaborative for Health Improvement to address the health gap created by the city’s wide income discrepancy by bringing technology to underserved communities. 

“Our team is passionate about this work and committed to doing what we can to address the 13 year life expectancy gap that exists between wealthy and poor areas of metro Atlanta,” says Dr. Ide.